^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

muparfostat (PI-88)

i
Other names: PI-88
Associations
Trials
Company:
Cellxpert Biotechnology Corp, Medigen Biotech
Drug class:
FGFR inhibitor, VEGFR inhibitor
Related drugs:
Associations
Trials
over3years
Heparanome-mediated rescue of oligodendrocyte progenitor quiescence following inflammatory demyelination. (PubMed, J Neurosci)
We found that PI-88, a heparan sulfate mimetic, directly antagonized IFN-γ to rescue human OPC proliferation and differentiation in vitro and blocked the IFN-γ mediated inhibitory effects on OPC recruitment in vivo Importantly, heparanase modulation by PI-88 or OGT2155 in demyelinated lesion rescued IFN-γ mediated axonal damage and demyelination...We find that pathological interferon-gamma can be blocked by modulation of the heparanome following demyelination using either a heparan mimetic or by treatment with heparanase inhibitor. These studies establish the potential for modulation of heparanome as a regenerative approach in demyelinating disease.
Journal
|
IFNG (Interferon, gamma)
|
muparfostat (PI-88)